semaglutide fda approval weight loss The approved a pill version of the GLP-1 receptor agonist (Wegovy), making it the first oral GLP-1 agent indicated for loss, Novo Nordisk announced on Monday. The once-daily 25 FDA approves first-ever oral GLP-1RA

While both Ozempic and Wegovy are the same drug, semaglutide, given by weekly injection, there are some key differences between the two

So, if youre thinking about giving this a shot, take it slow, listen to your body, and keep your doctor in the loop

They can provide personalized advice and ensure there are no risks based on your specific circumstances

Patients should avoid injecting into the same spot repeatedly and maintain a rotation schedule, waiting at least one week before returning to a previously used site

Key Takeaways Different FDA Approvals : Wegovy is FDA-approved specifically for chronic weight management in adults with obesity (BMI 30) or weight-related conditions (BMI 27), while Ozempic is FDA-approved only for type 2 diabetes management

Yet, the stalling part, or the plateau, is essential the scales arent moving because our body is adjusting to change